|
Volumn 55, Issue 10, 2006, Pages 1525-1526
|
Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CREATININE;
LIVER ENZYME;
MERCAPTOPURINE;
MESALAZINE;
PLACEBO;
ABDOMINAL PAIN;
ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD;
ALOPECIA;
ANEMIA;
ANKYLOSING SPONDYLITIS;
ARTHRALGIA;
CHOLECYSTITIS;
CLINICAL TRIAL;
CREATININE BLOOD LEVEL;
CROHN DISEASE;
DIARRHEA;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
ENZYME BLOOD LEVEL;
FLATULENCE;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
INTESTINE OBSTRUCTION;
LETTER;
LEUKOPENIA;
MYALGIA;
PANCREATITIS;
PHLEBITIS;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RECURRENT DISEASE;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
VOMITING;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
AZATHIOPRINE;
COLITIS, ULCERATIVE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MESALAMINE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
|
EID: 33749189358
PISSN: 00175749
EISSN: None
Source Type: Journal
DOI: 10.1136/gut.2006.099143 Document Type: Letter |
Times cited : (60)
|
References (3)
|